Skip to main content
. Author manuscript; available in PMC: 2010 Feb 11.
Published in final edited form as: Vaccine. 2008 Dec 16;27(7):1050–1054. doi: 10.1016/j.vaccine.2008.11.100

Figure 3. The frequency and timing (days post-vaccination) of reported congestion (LAIV) and arm soreness (TIV) by vaccine group.

Figure 3

LAIV (live-attenuated influenza vaccine [FluMist®]); TIV (inactivated vaccine [Fluzone®])